These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 2572687

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Fatal massive hepatic necrosis: a probable hypersensitivity reaction to sulfasalazine.
    Ribe J, Benkov KJ, Thung SN, Shen SC, LeLeiko NS.
    Am J Gastroenterol; 1986 Mar; 81(3):205-8. PubMed ID: 2869683
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The safety of sulfasalazine: the gastroenterologists' experience.
    Sachar DB.
    J Rheumatol Suppl; 1988 Sep; 16():14-6. PubMed ID: 2903923
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hepatotoxicity after treatment with sulfasalazine.
    Haines JD.
    Postgrad Med; 1986 May 01; 79(6):193-4, 197-8. PubMed ID: 2871549
    [Abstract] [Full Text] [Related]

  • 9. Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease.
    Tolia V.
    Am J Gastroenterol; 1992 Aug 01; 87(8):1029-32. PubMed ID: 1353658
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hepatotoxicity of salicylazosulfapyridine: a case report and review of the literature.
    Gulley RM, Mirza A, Kelly CE.
    Am J Gastroenterol; 1979 Nov 01; 72(5):561-4. PubMed ID: 43669
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Selective erythroid and magakaryocytic aplasia after sulfasalazine administration.
    Davies GE, Palek J.
    Arch Intern Med; 1980 Aug 01; 140(8):1122. PubMed ID: 6104949
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Successfully treated sulphasalazine-induced fulminant hepatic failure, thrombocytopenia and erythroid hypoplasia with intravenous immunoglobulin.
    Huang JL, Hung IJ, Chen LC, Lee WY, Hsueh C, Hsieh KH.
    Clin Rheumatol; 1998 Aug 01; 17(4):349-52. PubMed ID: 9776124
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hypersensitivity to salicylazosulfapyridine: renal and hepatic toxic reactions.
    Chester AC, Diamond LH, Schreiner GE.
    Arch Intern Med; 1978 Jul 01; 138(7):1138-9. PubMed ID: 27155
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Azulfidine- (sulfasalazine-) induced hepatic injury.
    Kanner RS, Tedesco FJ, Kalser MH.
    Am J Dig Dis; 1978 Oct 01; 23(10):956-8. PubMed ID: 31085
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.